TickerFacts.

Company research / RPRX

Royalty Pharma plc (RPRX)

Build a valuation ↗↓ Download CSV

CIK 0001802768 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Royalty Pharma plc reported revenue of $2.38B. Revenue grew 5.1% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $2.54B.

Key ratios (year ended 2025-12-31)

65.6%
Operating margin
32.4%
Net margin
7.9%
Return on year-end equity
5.1%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-10-05

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Revenue$2.54B$2.38B$2.26B$2.35B$2.24B$2.29B$2.12B$1.81B$1.79B
R&D Expense$238.64M$452.00M$2.00M$52.00M$177.11M$200.08M$26.29M$83.04M$392.61M
Operating Income$1.51B$1.56B$1.29B$1.49B$307.06M$1.43B$1.60B$2.62B$1.36B
Net Incomen/a$770.95M$858.98M$1.13B$42.83M$619.73M$975.04M$2.35B$1.38B
EPS (Diluted)n/a$1.78$1.91$2.53$0.10$1.49$1.32n/an/a
Total Assets$19.82B$19.62B$18.22B$16.38B$16.81B$17.52B$16.02B$12.45Bn/a
Total Liabilities$10.03B$9.91B$7.88B$6.30B$7.29B$7.27B$6.12B$6.31Bn/a
Long-Term Debt$8.96B$8.95B$7.61B$6.14B$7.12B$7.10B$5.82Bn/an/a
Shareholders' Equity$9.79B$9.71B$10.34B$10.08B$9.53B$10.25B$9.90B$6.14B$4.55B
Cash & Equivalents$811.99M$618.70M$929.03M$477.01M$1.71B$1.54B$1.01B$246.20Mn/a
Operating Cash Flow$2.98B$2.49B$2.77B$2.99B$2.14B$2.02B$2.03B$1.67B$1.62B
Share Repurchases$321.77M$1.23B$229.65M$304.76M$0$0$0$4.27M$0
Dividends Per Sharen/an/a$0.84$0.80$0.76$0.68$0.30n/an/a
Weighted Average Diluted Sharesn/a564.46M594.11M602.90M437.97M414.80M375.45Mn/an/a
EPS (Basic)n/a$1.79$1.92$2.54$0.10$1.49$1.32n/an/a

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView